Addex to present at the bio-europe spring 2024 conference

Geneva, switzerland, march 14, 2024 – addex therapeutics (six: adxn), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that ceo, tim dyer, will present at the bio-europe spring 2024 conference taking place march 18 - 20, 2024 in barcelona, spain. dr. robert lÜtjens, head of discovery – biology, will also be attending this event.
ADXN Ratings Summary
ADXN Quant Ranking